Bondex Block Filler and Primer (1961–1977)

Product Description

Bondex Block Filler and Primer was a surface preparation coating manufactured by Bondex International, marketed for use on concrete masonry units, cinder block, and other porous substrates. The product was designed to fill the open pores and irregular surface texture of concrete block walls before finish coats of paint or other wall coverings were applied. By sealing and leveling the substrate surface, the filler-primer reduced paint consumption and improved adhesion of subsequent coatings.

The product was widely used in commercial and industrial construction throughout the period of its manufacture, from approximately 1961 to 1977. Industrial facilities, warehouses, manufacturing plants, and institutional buildings constructed during these decades frequently incorporated concrete masonry unit walls that required surface treatment, making Bondex Block Filler and Primer a commonly encountered product on large-scale job sites. The formulation was sold under the Bondex brand, which was known during this era for a range of construction-related coatings and patching compounds that, litigation records document, contained asbestos-bearing ingredients as part of their manufactured composition.

Asbestos Content

Litigation records document that Bondex Block Filler and Primer manufactured between 1961 and 1977 contained chrysotile asbestos as a component of its formulation. Chrysotile, sometimes referred to as white asbestos, is a serpentine mineral fiber that was widely incorporated into construction products during the mid-twentieth century for its binding properties, its ability to reinforce thin-film coatings, and its resistance to cracking and shrinkage as products dried or cured.

In products of this category — thick, paste-like or semi-liquid coatings intended for application to rough masonry surfaces — chrysotile fibers served both functional and economic purposes. The fibrous structure of chrysotile helped suspend solids in the product during storage and application, contributed to the build characteristics of the coating, and improved the film’s durability after it dried. Plaintiffs alleged that these functional benefits led Bondex to incorporate chrysotile asbestos into the block filler formulation throughout the production period documented in litigation records.

Chrysotile asbestos is regulated as a known human carcinogen by federal health authorities. OSHA standards codified in 29 C.F.R. § 1910.1001 and 29 C.F.R. § 1926.1101 establish permissible exposure limits and action levels for airborne asbestos fibers and apply to workplaces and construction environments where asbestos-containing materials may be disturbed. AHERA regulations further address asbestos-containing materials in building environments. No safe level of occupational asbestos exposure has been established by health authorities.

How Workers Were Exposed

Industrial workers who mixed, applied, sanded, or otherwise disturbed Bondex Block Filler and Primer during the product’s years of manufacture and use faced the potential for chrysotile asbestos fiber release. The nature of the work associated with this product created several distinct exposure pathways that litigation records document in connection with occupational disease claims.

Mixing and thinning operations presented a significant exposure risk. Block filler products of this type were commonly delivered in a thick consistency that required mixing before use, either by hand or with a mechanical paddle mixer. Plaintiffs alleged that the mixing process agitated the product and released asbestos-containing dust and fiber into the breathing zone of workers performing or standing near mixing operations.

Application by brush, roller, or spray represented an additional exposure route. Workers applying thick masonry coatings by brush or roller to large block wall surfaces worked in sustained close proximity to the material. Spray application, used on larger industrial projects to cover expansive wall areas more efficiently, was documented in litigation records as a particularly significant source of airborne fiber release, as the spray process atomized the coating and could distribute asbestos-containing particles throughout the work area.

Sanding and surface preparation after the product dried created additional hazards. Block filler coatings were sometimes lightly abraded or sanded to smooth the surface before finish painting. Plaintiffs alleged that sanding dried Bondex Block Filler and Primer generated fine asbestos-containing dust that became airborne and could be inhaled by workers performing sanding or by others working in the same space.

Bystander and secondary exposure is also reflected in litigation records involving industrial settings. Workers performing adjacent tasks — other tradespeople on multi-trade construction projects or industrial maintenance personnel — who were present when block filler was being mixed, applied, or disturbed may have been exposed to asbestos fibers without directly handling the product themselves.

Industrial workers generally, including maintenance painters, construction workers engaged in commercial masonry finishing, and facility maintenance personnel who encountered previously applied Bondex Block Filler and Primer during renovation or repair work, are among the occupational categories documented in connection with asbestos exposure claims related to products of this type.

Diseases associated with occupational asbestos exposure include mesothelioma, asbestosis, asbestos-related lung cancer, and other asbestos-related conditions. These diseases typically have latency periods of ten to fifty years between exposure and diagnosis, meaning individuals exposed to asbestos-containing products during the 1960s and 1970s may be receiving diagnoses decades after their period of occupational contact with these materials.

Bondex International does not have an active asbestos bankruptcy trust fund. As a result, legal claims associated with Bondex Block Filler and Primer are pursued through civil litigation rather than through a structured trust fund claims process.

Civil Litigation

Litigation records document that plaintiffs diagnosed with mesothelioma, asbestos-related lung cancer, asbestosis, and related conditions have brought civil claims in connection with Bondex asbestos-containing products, including block filler and primer formulations. Plaintiffs alleged that Bondex knew or should have known of the health hazards associated with chrysotile asbestos during the years the product was manufactured, and that the company failed to provide adequate warnings or to remove asbestos from its formulations despite the availability of safer alternatives.

Civil asbestos litigation may allow qualifying claimants to seek compensation for medical expenses, lost income, pain and suffering, and related damages. Claims involving Bondex products are typically filed against successor entities, parent companies, or other parties in the chain of distribution, depending on the corporate history applicable at the time of a claim.

Other Trust Fund Claims

In cases where a claimant was exposed to multiple asbestos-containing products across a career — as is common in industrial and construction settings — they may also be eligible to file claims with the asbestos bankruptcy trusts established by other manufacturers whose products were present on the same job sites. An experienced asbestos attorney can evaluate the full exposure history to identify all potentially responsible parties and applicable trust funds.

Individuals diagnosed with an asbestos-related disease following exposure to Bondex Block Filler and Primer or other asbestos-containing products should consult with an attorney experienced in asbestos litigation. Statutes of limitations apply to asbestos claims and vary by state; early consultation is advised to preserve legal rights.